ORPHALAN INNOVATION FOR ORPHAN DISEASES
LIVE

Serial Number

79296324

Owner

ORPHALAN

Attorney

Heather R. Smith-Carra

Filing Date

Sep 9, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ORPHALAN INNOVATION FOR ORPHAN DISEASES Trademark

Serial Number: 79296324 • Registration: 6599549

ORPHALAN INNOVATION FOR ORPHAN DISEASES is a trademark filed by ORPHALAN on September 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ORPHALAN (10 trademarks)

226 boulevard Voltaire

Entity Type: 33

Trademark Details

Filing Date

September 9, 2020

Registration Date

December 28, 2021

Published for Opposition

October 12, 2021

Goods & Services

diagnostic agents for pharmaceutical use; capsules sold empty for pharmaceutical use; pharmaceutical compounds for the treatment of orphan diseases; pharmaceutical products for the treatment of orphan diseases; chemical preparations for pharmaceutical use, namely, for the treatment of orphan diseases; chemical preparations for medical use, for the treatment of orphan diseases; medicines for the development of treatment for orphan diseases

Advice relating to pharmacy, namely, advice relating to the use of pharmaceuticals for the treatment of orphan diseases; advisory services relating to health; pharmaceutical advice; advice relating to medicines; information to patients on administering medicines; medical information; drug use testing service for medical use; pharmaceutical services, namely, pharmaceutical compounding services and information services relating to diagnostic, prophylactic and therapeutic properties of pharmaceutical products; medical testing and analysis services for diagnostic or treatment of orphan disease; health advisory services relating to the use and operation of medical apparatus and instruments for treatment of orphan disease; medical diagnosis of orphan diseases

Medical apparatus and instruments for diagnosing and treating orphan diseases; surgical apparatus and instruments; diagnostic apparatus for medical use for diagnosing orphan diseases; immunochemical testing apparatus for medical use; medical testing instruments for diagnosing and treating orphan diseases; substance analysis apparatus, namely, medical devices and medical instruments for the analysis of body fluids; instruments for extraction of liquids from the human body, namely, medical devices for obtaining body fluid samples; blood testing apparatus; radiology apparatus for medical use; blood testing instruments, namely, needles for medical use and veterinary use; resuscitation apparatus; gloves for medical use; gloves for veterinary use; syringes for medical use; fluid injectors for medical use; X-rays for medical use; inhalers for medical use; radiology screens for medical use; containers for applying medicines being medical tubing for administering drugs; special containers for medical waste; probes for medical use; thermometers for medical use; medical cases, namely, cases fitted for medical instruments; stethoscopes; heart pacemakers; electromagnetic diagnostic imaging apparatus for medical use; needles for medical use

Development of pharmaceutical preparations and medicines; development of pharmaceutical products; providing information on clinical studies for pharmaceutical products via an interactive website; evaluation of pharmaceutical products; scientific research in the field of pharmacy; research regarding pharmaceutical products; pharmaceutical research and development; research relating to pharmaceutical products; research and development for the pharmaceutical industry; conducting clinical trials for other in the field of pharmaceutical products; pharmaceutical drug development services; laboratory research services relating to pharmaceutical products; pharmaceutical research services; medical and pharmacological research services; pharmaceutical research and development services; Scientific research for medical purposes; scientific laboratory services; research and development in the field of biotechnology; design and development of medical diagnostic apparatus

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 9, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 9, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 28, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 28, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 3, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 3, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 3, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 4, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 22, 2021 GNFN
FINAL REFUSAL E-MAILED
Apr 22, 2021 GNFR
FINAL REFUSAL WRITTEN
Apr 22, 2021 CNFR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 10, 2021 ADCH
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 1, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 28, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 27, 2021 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 30, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 22, 2020 REPR